Cardiac MIBG Scan for Parkinsonism

Introduction

The cardiac I-123 MIBG (metaiodobenzylguanidine) scan is a nuclear medicine imaging test that assesses sympathetic cardiac innervation. MIBG is a norepinephrine analog that is taken up by sympathetic nerve endings via the norepinephrine transporter. In neurodegenerative diseases, loss of sympathetic innervation produces characteristic patterns that help differentiate between tauopathies and synucleinopathies^{1Cardiac sympathetic denervation in Parkinson disease2000 · Ann Intern Med · PMID 10979882Open reference}.

Mechanism

How MIBG Works

1. Radioactive Tracer: I-123 labeled MIBG is injected intravenously

2. Uptake: MIBG is taken up by sympathetic nerve terminals through the norepinephrine transporter (NET)

3. Imaging: Single-photon emission computed tomography (SPECT) images the distribution of MIBG in the heart

4. Quantification: Early and delayed images are compared to calculate the heart-to-mediastinum (H/M) ratio

Sympathetic Denervation in Neurodegeneration

• Synucleinopathies (PD, DLB, MSA): Loss of postganglionic sympathetic neurons → reduced MIBG uptake

• Tauopathies (PSP, CBS, AD): Relative preservation of cardiac sympathetic innervation → normal or near-normal uptake

Clinical Utility

Differentiating Tauopathies from Synucleinopathies

Sensitivity and Specificity

• Sensitivity for synucleinopathy: 80-90%

• Specificity for synucleinopathy: 85-95%

• Positive predictive value: High when combined with clinical assessment

• Negative predictive value: High for ruling out synucleinopathy in CBS/PSP

Interpretation

Early vs Delayed Imaging

Clinical Interpretation

• Preserved uptake (H/M >1.8): Suggests tauopathy (CBS, PSP) rather than synucleinopathy

• Reduced uptake (H/M <1.6): Suggests synucleinopathy (PD, DLB, MSA)

• Borderline (1.6-1.8): Correlate with clinical presentation; consider other tests

For This Patient

Given this patient’s:

• Negative alpha-synuclein seed amplification assay

• Clinical presentation suspicious for CBS or PSP

• DAT scan confirmed dopamine neuron loss

Cardiac MIBG scan would be expected to show:

• Normal/near-normal uptake if CBS/PSP (tauopathy)

• Reduced uptake if there is an synucleinopathy component

This test can help determine if there is mixed pathology (tau + synuclein) if uptake is borderline.

Practical Considerations

Cost and Access

Contraindications

• Absolute: Pregnancy, breastfeeding

• Relative: Recent beta-blocker use (interferes with uptake), clonidine

Test Procedure

1. Preparation: Fast for 4-6 hours; hold beta-blockers for 24 hours if possible

2. Injection: I-123 MIBG injected intravenously

3. Early imaging: 15-30 minutes post-injection

4. Delayed imaging: 3-4 hours post-injection

5. Total time: 4-5 hours

Comparison to Other Autonomic Tests

Complementary Diagnostic Approaches

Cardiac MIBG scintigraphy provides unique information about post-ganglionic sympathetic neurons that complements other autonomic assessments. Each test evaluates different components of the autonomic nervous system^{2Autonomic function testing in neurodegenerative diseases2023 · J Neurol Sci · PMID 38041967Open reference}.

When to Choose MIBG

MIBG is particularly valuable when:

1. Differential diagnosis is unclear between tauopathies (CBS, PSP) and synucleinopathies (PD, MSA, DLB)

2. Autonomic symptoms are ambiguous — MIBG provides objective sympathetic denervation evidence

3. Patient cannot tolerate invasive testing — MIBG is well-tolerated

4. Need to assess disease severity — MIBG uptake correlates with sympathetic neuron loss

Consider other tests when:

• Patient has contraindications to nuclear imaging (pregnancy)

• Need comprehensive autonomic evaluation (use full battery)

• Resource-limited settings (HRV and OH testing are more accessible)

Diagnostic Algorithm Integration

flowchart TD
    A["Suspected Atypical Parkinsonism"] --> B{"Cardiac MIBG"}
    B --> C{"H/M Ratio"}
    C -->|"Normal >1.8"| D["Tauopathy: CBS/PSP"]
    C -->|"Reduced <1.6"| E["Synucleinopathy: PD/MSA/DLB"]
    D --> F{"Confirm with Autonomic Tests"}
    E --> G{"Confirm with Autonomic Tests"}
    F --> H["Normal OH, HRV variable -> CBS/PSP"]
    G --> I["Severe OH, HRV reduced -> MSA"]
    G --> J["Mild OH, HRV moderate -> PD/DLB"]

Centers Offering MIBG Scanning

United States

International

Finding a Center

1. Movement disorder specialists — Ask neurologist for referral

2. Nuclear medicine departments — University hospitals typically offer MIBG

3. Autonomic disorder centers — Often have MIBG as part of evaluation

4. Clinical trials — Search ClinicalTrials.gov for “MIBG Parkinson” trials